Proof-of-concept studies using a Smoothened (Smo) inhibitor, demonstrated that blocking HH pathway activity inhibits tumor cell proliferation and increases apoptosis in a MB mouse model, Ptch1+/-Trp53-/-, resulting in eradication of even large spontaneous brain tumors [9]. Here, PTCH1 is linked to neoplasm.